Peapack Gladstone Financial Corp Catalent, Inc. Transaction History

Peapack Gladstone Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 26, 2024	SELL	$56.16 - $60.96 $56 - $60	-1 Reduced 0.02%	4,733 $287,000
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $253,647 - $269,932	4,734 New	4,734 $266,000
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $2,092 - $2,737	24 Added 1.15%	2,105 $226,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $5,557 - $7,344	59 Added 2.92%	2,081 $231,000
Q4 2021 Feb 15, 2022	BUY	$119.57 - $139.07 $6,337 - $7,370	53 Added 2.69%	2,022 $259,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $214,955 - $280,287	1,969 New	1,969 $262,000
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $199,873 - $246,656	-1,969 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $169,097 - $207,453	1,969 New	1,969 $205,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Peapack Gladstone Financial Corp with notifications on news.